These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12522449)

  • 41. An update on the management of peripheral T-cell lymphoma and emerging treatment options.
    Phillips AA; Owens C; Lee S; Bhagat G
    J Blood Med; 2011; 2():119-29. PubMed ID: 22287871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
    Nasr R; El Hajj H; Kfoury Y; de Thé H; Hermine O; Bazarbachi A
    Viruses; 2011 Jun; 3(6):750-69. PubMed ID: 21994752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?
    Chandesris MO; Ghez D; Besson C; Suarez F; Delarue R; Rubio MT; Bazarbachi A; Varet B; Hermine O
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21829417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients.
    Ishitsuka K; Katsuya H; Toyota T; Ishizu M; Kunami N; Fujita M; Sasaki H; Takamatsu Y; Uchiyama M; Fujikane H; Ogata K; Hara S; Tamura K
    Int J Hematol; 2010 Dec; 92(5):762-4. PubMed ID: 21080125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes.
    Fang JL; Beland FA
    Toxicol Sci; 2009 Sep; 111(1):120-30. PubMed ID: 19541796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.
    Tsukasaki K; Hermine O; Bazarbachi A; Ratner L; Ramos JC; Harrington W; O'Mahony D; Janik JE; Bittencourt AL; Taylor GP; Yamaguchi K; Utsunomiya A; Tobinai K; Watanabe T
    J Clin Oncol; 2009 Jan; 27(3):453-9. PubMed ID: 19064971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.
    Agbottah E; Yeh WI; Berro R; Klase Z; Pedati C; Kehn-Hall K; Wu W; Kashanchi F
    AIDS Res Ther; 2008 Jun; 5():12. PubMed ID: 18544167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult T-cell leukaemia/lymphoma.
    Matutes E
    J Clin Pathol; 2007 Dec; 60(12):1373-7. PubMed ID: 18042693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.
    Ramos JC; Ruiz P; Ratner L; Reis IM; Brites C; Pedroso C; Byrne GE; Toomey NL; Andela V; Harhaj EW; Lossos IS; Harrington WJ
    Blood; 2007 Apr; 109(7):3060-8. PubMed ID: 17138822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.
    Datta A; Bellon M; Sinha-Datta U; Bazarbachi A; Lepelletier Y; Canioni D; Waldmann TA; Hermine O; Nicot C
    Blood; 2006 Aug; 108(3):1021-9. PubMed ID: 16569765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human T cell lymphotropic virus-associated leukemia/lymphoma.
    Ratner L
    Curr Opin Oncol; 2005 Sep; 17(5):469-73. PubMed ID: 16093798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult T cell leukemia lymphoma.
    Ratner L
    Front Biosci; 2004 Sep; 9():2852-9. PubMed ID: 15353320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of T-cell non-Hodgkin's lymphoma.
    Evens AM; Gartenhaus RB
    Curr Treat Options Oncol; 2004 Aug; 5(4):289-303. PubMed ID: 15233906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.
    White JD; Wharfe G; Stewart DM; Maher VE; Eicher D; Herring B; Derby M; Jackson-Booth PG; Marshall M; Lucy D; Jain A; Cranston B; Hanchard B; Lee CC; Top LE; Fleisher TA; Nelson DL; Waldmann TA
    Leuk Lymphoma; 2001 Jan; 40(3-4):287-94. PubMed ID: 11426550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
    Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
    Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
    Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
    Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
    Bazarbachi A; Hermine O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S186-90. PubMed ID: 8797722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
    Ishitsuka K; Tsukasaki K; Tamura K
    Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
    Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
    Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.